September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
September 26, 2017 — The one-year results of the SENTRY clinical trial were presented by principal investigator Michael ...
September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial ...
September 22, 2017 — The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation s ...
September 21, 2017 — Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for ...
September 21, 2017 — MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 ...
September 19, 2017 — The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain ...
September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of ...
September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to ...
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra ...
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according ...
September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as ...
September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a limited ...